A Study to Assess Safety and Efficacy of Odanacatib (MK-0822) in Men With Osteoporosis (MK-0822-053)
Clinical trial NCT01120600 · COMPLETED
Trial details
- NCT number
- NCT01120600
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-06-09
- Primary completion
- 2013-07-22
- Enrollment
- 294
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.